HPV vaccine study for people aged 9 to 45
Part of Infections, Skin clinical trials.
This trial tests a new 15-valent HPV vaccine to see if it is safe and creates a strong immune response. If you are between 9 and 45 years old and have not had an HPV vaccine before, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 9 and 45 years old.
- You have never received any HPV vaccine before.
- You are in general good health, with no serious medical conditions like cancer, autoimmune disease, or severe allergies.
- If you are a woman of childbearing age, you must not be pregnant, not breastfeeding, and willing to use birth control during the study and for 30 days after the last shot.
- You are willing to follow the study schedule and not join another clinical trial at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
This trial studies whether a quadrivalent HPV vaccine is safe and helps the body build protection (immunity) against HPV. It enrolls healthy Chinese females who are not already treated for HPV-related infection.
This study checks how well two types of domestic HPV vaccines and one imported HPV vaccine boost your immune system. It is for girls aged 13-14 who have already finished their HPV vaccine shots about a month ago.
This trial tests how well the HPV vaccine triggers immune memory in women who may have been exposed to HPV. It could help protect against future HPV infections and related cancers.
This study tests a 9-valent HPV vaccine (protects against 9 types of human papillomavirus) in women who have already completed a previous HPV vaccine series. Researchers will check how safe the new vaccine is and how well your immune system responds to it.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.